Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hepatitis

  Free Subscription


04.09.2017

1 Ann Intern Med
2 BMC Gastroenterol
3 Eur J Gastroenterol Hepatol
1 Gut
4 Hepatology
1 J Clin Gastroenterol
3 J Hepatol
1 J Infect Dis
5 J Med Virol
1 J Viral Hepat
1 Lancet Infect Dis
1 N Engl J Med
1 Pediatrics
5 PLoS One
2 Transplantation


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Intern Med

  1. BEN-YAKOV G, Devika K, Etzion O, Koh C, et al
    A Misleading Pattern of Serologic Findings During Hepatitis B Virus Infection.
    Ann Intern Med. 2017 Aug 29. doi: 10.7326/L17-0369.
    PubMed     Text format    


    BMC Gastroenterol

  2. XU Y, Wang X, Liu Z, Zhou C, et al
    Addition of nucleoside analogues to peg-IFNalpha-2a enhances virological response in chronic hepatitis B patients without early response to peg-IFNalpha-2a: a randomized controlled trial.
    BMC Gastroenterol. 2017;17:102.
    PubMed     Text format     Abstract available

  3. SANAI FM, Farah T, Albeladi K, Batwa F, et al
    Diminished accuracy of biomarkers of fibrosis in low replicative chronic hepatitis B.
    BMC Gastroenterol. 2017;17:101.
    PubMed     Text format     Abstract available


    Eur J Gastroenterol Hepatol

  4. DOLMAZASHVILI E, Abutidze A, Chkhartishvili N, Karchava M, et al
    Regression of liver fibrosis over a 24-week period after completing direct-acting antiviral therapy in patients with chronic hepatitis C receiving care within the national hepatitis C elimination program in Georgia: results of hepatology clinic HEPA e
    Eur J Gastroenterol Hepatol. 2017 Aug 29. doi: 10.1097/MEG.0000000000000964.
    PubMed     Text format     Abstract available

  5. SIMS OT, Guo Y, Shoreibah MG, Venkata K, et al
    Alcohol and substance use, race, and insurance status predict nontreatment for hepatitis C virus in the era of direct acting antivirals: a retrospective study in a large urban tertiary center.
    Eur J Gastroenterol Hepatol. 2017 Aug 29. doi: 10.1097/MEG.0000000000000961.
    PubMed     Text format     Abstract available

  6. MANGLA N, Mamun R, Weisberg IS
    Viral hepatitis screening in transgender patients undergoing gender identity hormonal therapy.
    Eur J Gastroenterol Hepatol. 2017 Aug 29. doi: 10.1097/MEG.0000000000000950.
    PubMed     Text format     Abstract available


    Gut

  7. HUANG F, Long F, Yu W, Situ J, et al
    High prevalence of hepatitis E virus in semen of infertile male and causes testis damage.
    Gut. 2017 Aug 31. pii: gutjnl-2017-314884. doi: 10.1136/gutjnl-2017-314884.
    PubMed     Text format    


    Hepatology

  8. STEINMETZ C, Kashyap A, Zhivkova N, Alizor H, et al
    Activation of SIRT1 by human chorionic gonadotropin exerts a therapeutic effect on hepatic injury and inflammation.
    Hepatology. 2017 Jan 21. doi: 10.1002/hep.29072.
    PubMed     Text format     Abstract available

  9. PAPATHEODORIDIS GV, Manolakopoulos S, Su TH, Siakavellas S, et al
    Significance of definitions of relapse after discontinuation of oral antivirals in HBeAg-negative chronic hepatitis B.
    Hepatology. 2017 Aug 31. doi: 10.1002/hep.29497.
    PubMed     Text format     Abstract available

  10. TRIVEDI S, Murthy S, Sharma H, Hartlage AS, et al
    Viral persistence, liver disease and host response in Hepatitis C-like virus rat model.
    Hepatology. 2017 Aug 31. doi: 10.1002/hep.29494.
    PubMed     Text format     Abstract available

  11. MANATSATHIT W, Samant H, Nakayuenyongsuk W
    Mesenchymal stem cells for hepatitis B patients with acute on chronic liver failure-Are we there?
    Hepatology. 2017 Aug 31. doi: 10.1002/hep.29493.
    PubMed     Text format    


    J Clin Gastroenterol

  12. YU JH, Kim JK, Lee KS, Lee JI, et al
    Antiviral Therapy in Patients With Chronic Hepatitis C-related Hepatocellular Carcinoma Responding to Palliative Treatment.
    J Clin Gastroenterol. 2017 Aug 31. doi: 10.1097/MCG.0000000000000923.
    PubMed     Text format     Abstract available


    J Hepatol

  13. MALLET V, Bruneau J, Zuber J, Alanio C, et al
    Hepatitis E Virus-Induced Primary Cutaneous CD30(+) T cell Lymphoproliferative Disorder.
    J Hepatol. 2017 Aug 28. pii: S0168-8278(17)32250.
    PubMed     Text format     Abstract available

  14. KRAMER L, Laurain A, Sultanik P, Tremeaux P, et al
    "Empirical" retreatment of patients with chronic hepatitis C who failed a first direct-acting antiviral-based regimen.
    J Hepatol. 2017 Aug 23. pii: S0168-8278(17)32251.
    PubMed     Text format    

  15. GARVEY P, Murphy N, Flanagan P, Brennan A, et al
    Disease Outcomes in a Cohort of Women Infected by Hepatitis C-Contaminated anti-D Immunoglobulin During 1970s.
    J Hepatol. 2017 Aug 23. pii: S0168-8278(17)32249.
    PubMed     Text format     Abstract available


    J Infect Dis

  16. LIU J, Qiu S, Lu J, Yan B, et al
    Robust Antibody and Cytokine Response to Hepatitis B Vaccine Among Not-in-Treatment Patients With Chronic Hepatitis C: An Open-Label Control Study in China.
    J Infect Dis. 2017;216:327-335.
    PubMed     Text format     Abstract available


    J Med Virol

  17. MA X, Sun D, Li C, Ying J, et al
    Chronic hepatitis B virus infection and preterm labor(birth) in pregnant women-An updated systematic review and meta-analysis.
    J Med Virol. 2017 Aug 29. doi: 10.1002/jmv.24927.
    PubMed     Text format     Abstract available

  18. DEHGHANI-DEHEJ F, Sarvari J, Esghaei M, Hosseini SY, et al
    Presence of Different Hepatitis C Virus Genotypes in Plasma and Peripheral Blood Mononuclear Cell Samples of Iranian Patients with HIV Infection.
    J Med Virol. 2017 Aug 28. doi: 10.1002/jmv.24925.
    PubMed     Text format     Abstract available

  19. SHEPHERD SJ, McDonald SA, Palmateer NE, Gunson RN, et al
    HCV avidity as a tool for detection of recent HCV infection: sensitivity depends on HCV genotype.
    J Med Virol. 2017 Aug 26. doi: 10.1002/jmv.24919.
    PubMed     Text format     Abstract available

  20. SCHNELL G, Tripathi R, Krishnan P, Beyer J, et al
    Resistance Characterization of Hepatitis C Virus Genotype 2 from Japanese Patients Treated with Ombitasvir and Paritaprevir/Ritonavir.
    J Med Virol. 2017 Aug 26. doi: 10.1002/jmv.24923.
    PubMed     Text format     Abstract available

  21. MAHMUD S, Kanaani ZA, Chemaitelly H, Chaabna K, et al
    Hepatitis C Virus Genotypes in the Middle East and North Africa: Distribution, Diversity, and Patterns.
    J Med Virol. 2017 Aug 26. doi: 10.1002/jmv.24921.
    PubMed     Text format     Abstract available


    J Viral Hepat

  22. SERPER M, Forde KA, Kaplan DE
    Rare clinically significant hepatic events and hepatitis B reactivation occur more frequently following rather than during direct-acting antiviral therapy for chronic hepatitis C: data from a national US cohort.
    J Viral Hepat. 2017 Aug 28. doi: 10.1111/jvh.12784.
    PubMed     Text format     Abstract available


    Lancet Infect Dis

  23. BALAKRISHNAN VS
    Essential medicines for hepatitis C: at what price?
    Lancet Infect Dis. 2017;17:904-905.
    PubMed     Text format    


    N Engl J Med

  24. REILLEY B, Leston J
    A Tale of Two Epidemics - HCV Treatment among Native Americans and Veterans.
    N Engl J Med. 2017;377:801-803.
    PubMed     Text format    


    Pediatrics


  25. Elimination of Perinatal Hepatitis B: Providing the First Vaccine Dose Within 24 Hours of Birth.
    Pediatrics. 2017 Aug 28. pii: e20171870. doi: 10.1542/peds.2017-1870.
    PubMed     Text format     Abstract available


    PLoS One

  26. KJAERGAARD M, Thiele M, Jansen C, Staehr Madsen B, et al
    High risk of misinterpreting liver and spleen stiffness using 2D shear-wave and transient elastography after a moderate or high calorie meal.
    PLoS One. 2017;12:e0173992.
    PubMed     Text format     Abstract available

  27. HERMETET C, Dubois F, Gaudy-Graffin C, Bacq Y, et al
    Continuum of hepatitis C care in France: A 20-year cohort study.
    PLoS One. 2017;12:e0183232.
    PubMed     Text format     Abstract available

  28. SHIER MK, Iles JC, El-Wetidy MS, Ali HH, et al
    Molecular characterization and epidemic history of hepatitis C virus using core sequences of isolates from Central Province, Saudi Arabia.
    PLoS One. 2017;12:e0184163.
    PubMed     Text format     Abstract available

  29. MORSICA G, Bagaglio S, Spagnuolo V, Castagna A, et al
    Immune response to hepatitis B vaccination in HIV-positive individuals with isolated antibodies against hepatitis B core antigen: Results of a prospective Italian study.
    PLoS One. 2017;12:e0184128.
    PubMed     Text format     Abstract available

  30. GARBA RM, Gadanya MA
    The role of intervention mapping in designing disease prevention interventions: A systematic review of the literature.
    PLoS One. 2017;12:e0174438.
    PubMed     Text format     Abstract available


    Transplantation

  31. CHOLANKERIL G, Li AA, Yoo ER, Ahmed A, et al
    Direct-Acting Antiviral Therapy and Improvement in Graft Survival of Hepatitis C Liver Transplant Recipients.
    Transplantation. 2017 Aug 24. doi: 10.1097/TP.0000000000001926.
    PubMed     Text format    

  32. ANTONINI TM, Coilly A, Rossignol E, Fougerou-Leurent C, et al
    Sofosbuvir-based Regimens in HIV/HCV Coinfected Patients after Liver Transplantation: Results from the ANRS CO23 CUPILT Study.
    Transplantation. 2017 Aug 24. doi: 10.1097/TP.0000000000001928.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: